News Daily News FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients L.A. McKeown August 21, 2024
News Conference News THT 2024 Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients Michael O'Riordan March 07, 2024
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018